Temasek Holdings Portfolio holdings
AUM
$25.8B
1-Year Return
43.86%
This Quarter Return
+8.65%
1 Year Return
+43.86%
3 Year Return
+113.28%
5 Year Return
+128.2%
10 Year Return
+403.09%
AUM
$17.2B
AUM Growth
+$1.66B
(+11%)
Cap. Flow
+$602M
Cap. Flow
% of AUM
3.5%
Top 10 Holdings %
Top 10 Hldgs %
78.01%
Holding
63
New
4
Increased
16
Reduced
1
Closed
2
Top Buys
| 1 |
Visa
V
|
$186M |
| 2 |
Virtu Financial
VIRT
|
$130M |
| 3 |
Trip.com Group
TCOM
|
$103M |
| 4 |
Mastercard
MA
|
$92.6M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$87.5M |
Top Sells
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$169M |
| 2 |
LKM
Link Motion Inc.
LKM
|
$828K |
| 3 |
Cognizant
CTSH
|
$724K |
Sector Composition
| 1 | Consumer Discretionary | 41.74% |
| 2 | Industrials | 21.19% |
| 3 | Healthcare | 12.8% |
| 4 | Financials | 7.52% |
| 5 | Materials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Regeneron Pharmaceuticals
REGN
$60.8B
| $85.2M | 0.5% |
190,621
+13,068
| +7% | +$5.84M |
|
|
WP
27
DELISTED
Worldpay, Inc.
WP
| $69.2M | 0.4% |
+982,057
| New | +$69.2M |
|
|
TOUR
28
Tuniu
TOUR
$102M
| $64.1M | 0.37% |
8,194,444
| – | – |
|
|
VNET
29
VNET Group
VNET
$2.13B
| $61.3M | 0.36% |
10,778,004
| – | – |
|
30
Illumina
ILMN
$15.7B
| $55.2M | 0.32% |
285,024
| – | – |
|
|
MON
31
DELISTED
Monsanto Co
MON
| $51.4M | 0.3% |
429,184
+213,650
| +99% | +$25.6M |
|
|
KREF
32
KKR Real Estate Finance Trust
KREF
$648M
| $51.3M | 0.3% |
2,439,024
| – | – |
|
|
ATH
33
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $46.4M | 0.27% |
862,204
| – | – |
|
|
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
| $41.1M | 0.24% |
915,750
| – | – |
|
|
EMWP
35
DELISTED
Eros Media World PLC
EMWP
| $39.4M | 0.23% |
137,766
| – | – |
|
|
ONC
36
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $39.3M | 0.23% |
380,000
| – | – |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $37.2M | 0.22% |
255,406
+49,219
| +24% | +$7.18M |
|
38
Vertex Pharmaceuticals
VRTX
$102B
| $37.2M | 0.22% |
244,582
+50,383
| +26% | +$7.66M |
|
39
Biogen
BIIB
$20.6B
| $37.2M | 0.22% |
118,644
+23,418
| +25% | +$7.33M |
|
40
Amgen
AMGN
$153B
| $35.2M | 0.2% |
188,527
+37,217
| +25% | +$6.94M |
|
41
Incyte
INCY
$16.9B
| $29.4M | 0.17% |
252,160
+50,856
| +25% | +$5.94M |
|
42
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $29.3M | 0.17% |
515,700
| – | – |
|
|
NETS
43
DELISTED
Netshoes (Cayman) Limited
NETS
| $27.2M | 0.16% |
2,071,127
| – | – |
|
44
JPMorgan Chase
JPM
$809B
| $25.2M | 0.15% |
264,337
| – | – |
|
45
ICICI Bank
IBN
$113B
| $24M | 0.14% |
2,808,987
| – | – |
|
46
Bank of America
BAC
$369B
| $20.2M | 0.12% |
798,123
| – | – |
|
47
Intellia Therapeutics
NTLA
$1.29B
| $19.6M | 0.11% |
790,527
| – | – |
|
48
AC Immune
ACIU
$229M
| $14.9M | 0.09% |
1,337,500
| – | – |
|
49
Wells Fargo
WFC
$253B
| $14.4M | 0.08% |
260,364
| – | – |
|
|
AMRS
50
DELISTED
Amyris Inc.
AMRS
| $10.6M | 0.06% |
3,302,585
| – | – |
|